Showing results (331-340 of 349) with videos related to
Sort By:
Pageof 35
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 21, 2017
Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for Stage III non-small-cell lung cancerKyle Wang, Kevin A Pearlstein, Nicholas D Patchett, et al.International Journal of Radiation Oncology, Biology, Physics|August 22, 2021
Coronary Artery Calcifications and Cardiac Risk After Radiation Therapy for Stage III Lung CancerKyle Wang, Hayley E Malkin, Nicholas D Patchett, et al.International Journal of Radiation Oncology, Biology, Physics|September 18, 2007
Multi-institutional review of repeat irradiation of chest wall and breast for recurrent breast cancerAndrew O Wahl, Alfred Rademaker, Krystyna D Kiel, et al.The Lancet. Oncology|July 26, 2021
Survival outcomes in older men with non-metastatic castration-resistant prostate cancer treated with androgen receptor inhibitors: a US Food and Drug Administration pooled analysis of patient-level data from three randomised trialsJaleh Fallah, Lijun Zhang, Anup Amatya, et al.Urology|August 2, 2008
A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancerEdouard J Trabulsi, Richard K Valicenti, Alexandra L Hanlon, et al.International Journal of Radiation Oncology, Biology, Physics|November 20, 2013
Current status and recommendations for the future of research, teaching, and testing in the biological sciences of radiation oncology: report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, executive summaryPaul E Wallner, Mitchell S Anscher, Christopher A Barker, et al.The Oncologist|November 4, 2020
FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA-Mutated Metastatic Castrate-Resistant Prostate CancerMitchell S Anscher, Elaine Chang, Xin Gao, et al.International Journal of Radiation Oncology, Biology, Physics|September 15, 2009
Impact of high-dose chemotherapy on the ability to deliver subsequent local-regional radiotherapy for breast cancer: analysis of Cancer and Leukemia Group B Protocol 9082Lawrence B Marks, Constance Cirrincione, Thomas J Fitzgerald, et al.The Lancet. Oncology|February 5, 2026
Reirradiation Collaborative Group (ReCOG) consensus on standards for dose evaluation and reporting in patients with multiple courses of radiation therapy: an AAPM/ACRO/ASTRO/CARO/COMP/CADRA/CPQR/ESTRO/NRG-endorsed consensus statementKelly C Paradis, Ane L Appelt, Soren M Bentzen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2015
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care GuidelineCarolyn D Runowicz, Corinne R Leach, N Lynn Henry, et al.Pageof 35